FARMACEUTICA REMEDIA SA financials
FARMACEUTICA REMEDIA SA
Country: RO Reporting currency: RON Latest annual report: 2022-12-31
LEI:
2549001TDHDVU72MQS59 Financial statements
(RON, as reported — unscaled; 110 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | RON 540.0M | RON 478.2M |
| Gross profit | RON 10.2M | RON 9.2M |
| Operating expenses | RON 532.5M | RON 469.2M |
| Employee benefits expense | RON 22.1M | RON 19.5M |
| Raw materials & consumables used | RON 3.5M | RON 2.0M |
| Depreciation & amortisation | RON 4.0M | RON 1.2M |
| Operating profit (EBIT) | RON 6.7M | RON 8.8M |
| Finance costs | RON 532.9K | RON 377.6K |
| Profit before tax | RON 7.1M | RON 8.6M |
| Income tax expense | RON 1.2M | RON 1.4M |
| Profit for the year | RON 5.8M | RON 7.2M |
| — attributable to owners | RON 5.8M | RON 7.2M |
| Total comprehensive income | RON 5.8M | RON 7.2M |
| Per share | ||
| Basic EPS | RON 0.06 | RON 0.08 |
| Diluted EPS | RON 0.06 | RON 0.08 |
| Cash flow statement | ||
| Net cash from operating activities | RON 2.0M | — |
| Net cash from investing activities | RON 239.5K | — |
| Net cash from financing activities | -RON 4.5M | — |
| Proceeds from borrowings | RON 0 | — |
| Net change in cash | -RON 54.9K | — |
| Balance sheet | ||
| Total assets | RON 286.2M | RON 251.1M |
| Non-current assets | RON 44.5M | RON 42.7M |
| Property, plant & equipment | RON 24.8M | RON 21.3M |
| Current assets | RON 240.9M | RON 206.2M |
| Inventories | RON 46.3M | RON 40.6M |
| Trade & other receivables | RON 173.7M | RON 137.6M |
| Cash & equivalents | RON 18.1M | RON 24.2M |
| Total equity | RON 68.4M | RON 68.2M |
| Non-current liabilities | RON 3.2M | RON 2.5M |
| Lease liabilities (non-current) | RON 3.2M | RON 2.5M |
| Current liabilities | RON 214.6M | RON 180.3M |
| Trade & other payables | RON 210.0M | RON 176.0M |
| Deferred tax liabilities | RON 0 | RON 0 |
| Derived metrics | ||
| Operating margin | 1.2% | 1.8% |
| Net margin | 1.1% | 1.5% |
| Return on equity | 8.5% | 10.6% |
| Cash conversion ratio | 0.34× | — |
| Other reported items | ||
| Comprehensive Income Attributable To Owners of Parent | RON 5.8M | RON 7.2M |
| Cost of Inventories Recognised As Expense During Period | RON 491.4M | RON 439.1M |
| Cost of Merchandise Sold | RON 495.5M | RON 445.0M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | RON 0 | RON 0 |
| Current Prepaid Expenses | RON 829.7K | RON 2.2M |
| Current Provisions | RON 217.3K | RON 217.3K |
| Deferred Tax Expense Income | RON 0 | -RON 297.5K |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | RON 4.1M | RON 1.8M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | RON 4.5M | — |
| Dividends Received Classified As Investing Activities | RON 79.8K | — |
| Dividends Recognised As Distributions To Owners of Parent | RON 4.8M | RON 14.3M |
| Energy Expense | RON 1.0M | RON 779.3K |
| Equity and Liabilities | RON 286.2M | RON 251.1M |
| Expense By Nature | RON 533.0M | RON 469.5M |
| Finance Income | RON 844.8K | RON 220.7K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | RON 330.2K | RON 168.8K |
| Income Taxes Paid Refund Classified As Operating Activities | RON 1.3M | — |
| Increase Decrease In Accounting Estimate | RON 0 | -RON 24.9K |
| Increase Decrease In Cash and Cash Equivalents | -RON 6.3M | — |
| Increase Decrease In Provision For Unearned Premium | -RON 279.3K | RON 414.5K |
| Increase Decrease Through Appropriation of Retained Earnings | RON 0 | RON 0 |
| Increase Decrease Through Transfer Between Revaluation Reserve and Retained Earnings | RON 0 | RON 0 |
| Increase Decrease Through Transfer To Statutory Reserve | RON 232.4K | — |
| Increase Decrease Through Transfers and Other Changes Property Plant and Equipment | RON 0 | RON 0 |
| Increase Decrease Through Treasury Share Transactions | RON 0 | -RON 6.4M |
| Interest Expense | RON 99.8K | RON 0 |
| Interest Expense On Lease Liabilities | RON 62.5K | RON 109.6K |
| Interest Paid Classified As Operating Activities | RON 65.9K | — |
| Interest Received Classified As Investing Activities | RON 0 | — |
| Interest Received Classified As Operating Activities | RON 386.6K | — |
| Interest Revenue Expense | RON 386.6K | RON 22.1K |
| Inventory Writedown2011 | RON 2.8M | RON 1.7M |
| Investment Property | RON 16.5M | RON 18.7M |
| Investments In Joint Ventures | RON 5.9K | RON 5.3K |
| Investments In Subsidiaries | RON 588.6K | RON 292.3K |
| Issued Capital | RON 9.9M | RON 9.9M |
| Lease Liabilities | RON 777.9K | RON 1.3M |
| Liabilities | RON 217.8M | RON 182.8M |
| Miscellaneous Other Operating Expense | RON 142.4K | RON 98.9K |
| Miscellaneous Other Operating Income | RON 3.4M | RON 847.3K |
| Net Foreign Exchange Gain | RON 99.9K | RON 13.2K |
| Net Foreign Exchange Loss | RON 180.0K | RON 74.2K |
| Noncurrent Finance Lease Receivables | RON 0 | RON 0 |
| Noncurrent Refunds Provision | RON 0 | RON 0 |
| Other Cash Receipts From Operating Activities | RON 26.2M | — |
| Other Current Liabilities | RON 3.1M | RON 2.8M |
| Other Current Receivables | RON 2.8M | RON 3.8M |
| Other Employee Expense | RON 1.9M | RON 1.4M |
| Other Expense By Nature | RON 2.2M | RON 344.2K |
| Other Finance Cost | RON 18.2K | RON 0 |
| Other Finance Income | RON 20.5K | RON 0 |
| Other Inflows Outflows of Cash Classified As Operating Activities | RON 24.6M | — |
| Other Operating Income Expense | -RON 14.8M | -RON 8.8M |
| Other Reserves | RON 40.0M | RON 44.1M |
| Payments From Changes In Ownership Interests In Subsidiaries | RON 0 | — |
| Payments To and On Behalf of Employees | RON 20.1M | — |
| Payments To Suppliers For Goods and Services | RON 520.7M | — |
| Proceeds From Other Longterm Assets Classified As Investing Activities | RON 197.7K | — |
| Purchase of Other Longterm Assets Classified As Investing Activities | RON 38.0K | — |
| Receipts From Sales of Goods and Rendering of Services | RON 547.2M | — |
| Repayments of Current Borrowings | RON 0 | — |
| Repayments of Noncurrent Borrowings | RON 0 | — |
| Retained Earnings | RON 12.5M | RON 6.7M |
| Revaluation Increase Decrease Property Plant and Equipment | -RON 506.5K | RON 1.8M |
| Revenue and Operating Income | RON 539.2M | RON 477.9M |
| Revenue From Contracts With Customers | RON 535.9M | RON 477.1M |
| Revenue From Dividends | RON 79.8K | RON 140.3K |
| Revenue From Sale of Goods | RON 531.0M | RON 474.5M |
| Reversal of Inventory Writedown | RON 8.8M | RON 8.7M |
| Share Premium | RON 757.5K | RON 757.5K |
| Social Security Contributions | RON 903.2K | RON 795.6K |
| Tax Expense Other Than Income Tax Expense | RON 1.9M | RON 990.4K |
| Wages and Salaries | RON 19.3M | RON 17.3M |
Methodology
Every line item above is a fact tagged in FARMACEUTICA REMEDIA SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (RON), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.